• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[外照射放疗与组织间近距离放疗治疗肛管癌:70例患者系列研究]

[External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].

作者信息

Dubois Jean-Bernard, Azria David, Ychou Marc

机构信息

Département de radiothérapie, CRLC Val d'Aurelle, 34298 Montpellier.

出版信息

Bull Cancer. 2003 Dec;90(12):1107-10.

PMID:14715430
Abstract

This study is concerning 70 patients (57 female, 13 male) with an epidermoid carcinoma of the anal canal which were treated homogeneously with a combination of an external beam radiation therapy ((45 Gy in 25 fractions of 1.8 Gy for 5 weeks) and a brachytherapy with Iridium wires (15 to 20 Gy delivered to the gross residual disease). The N1 patients and the patients with tumors more than 4 cm in diameter received a chemotherapy also (5 FU and cisplatinum). The overall local control was obtained in 68 cases out of 70 (97.1%). 63 out of 70 patients (90%) are alive and locally controlled. 56 pts out of 70 (80%) did have a preserved anus, and a normal sphincterian function was preserved in 53 pts out of 70 (75.7%). 17 pts had a colostomy (3 without and 14 with an abdominoperineal resection). With the salvage perineal resection, 11 patients out of 12 local recurrences were definitely locally cured (91.7%). The 5-year overall survival is 91.4%. The 5-year disease-free survival is 90%. The 5-year survival with preserved anal sphincter is 80% and with preserved sphincterian function is 75.7%. Five patients died from cancer (3 deaths due to metastases, and only 2 due to a locoregional evolution). These results have been analysed regarding the literature data and demonstrated the curative role of external beam and brachytherapy, in localized tumors, the contribution of chemotherapy in advanced stages and the efficiency of secondary salvage surgery in local recurrences.

摘要

本研究涉及70例肛管表皮样癌患者(57例女性,13例男性),均接受了外照射放疗(5周内分25次给予45 Gy,每次1.8 Gy)与铱丝近距离放疗(对大体残留病灶给予15至20 Gy)联合治疗。N1期患者及肿瘤直径超过4 cm的患者还接受了化疗(5-氟尿嘧啶和顺铂)。70例患者中有68例(97.1%)实现了总体局部控制。70例患者中有63例(90%)存活且局部得到控制。70例患者中有56例(80%)保留了肛门,70例患者中有53例(75.7%)保留了正常的括约肌功能。17例患者进行了结肠造口术(3例未行腹会阴联合切除术,14例进行了腹会阴联合切除术)。通过挽救性会阴切除术,12例局部复发患者中有11例(91.7%)确实实现了局部治愈。5年总生存率为91.4%。5年无病生存率为90%。保留肛门括约肌的5年生存率为80%,保留括约肌功能的5年生存率为75.7%。5例患者死于癌症(3例死于转移,仅2例死于局部进展)。已结合文献数据对这些结果进行了分析,结果表明外照射放疗和近距离放疗在局限性肿瘤中的治愈作用、化疗在晚期的作用以及二次挽救性手术在局部复发中的疗效。

相似文献

1
[External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].[外照射放疗与组织间近距离放疗治疗肛管癌:70例患者系列研究]
Bull Cancer. 2003 Dec;90(12):1107-10.
2
[Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].肛管表皮样癌采用放射治疗及同步化疗(5-氟尿嘧啶和顺铂)治疗
Cancer Radiother. 2006 Dec;10(8):572-82. doi: 10.1016/j.canrad.2006.09.116. Epub 2006 Nov 15.
3
Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.肿瘤部位可预测肛管鳞状细胞癌放化疗后的预后:101例患者的长期结果
Dis Colon Rectum. 2005 Sep;48(9):1742-51. doi: 10.1007/s10350-005-0098-5.
4
[The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].[肛管:两个周期的放化疗及后装近距离放疗]
Radiol Med. 1997 Apr;93(4):451-6.
5
Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.放射化学疗法在肛管癌保守治疗中的应用:结果及放射剂量有效性的回顾性分析
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1136-42. doi: 10.1016/j.ijrobp.2004.07.687.
6
[Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].[305例肛管表皮样癌患者接受根治性放射治疗的情况]
Cancer Radiother. 2003 Aug;7(4):237-53. doi: 10.1016/s1278-3218(03)00042-8.
7
Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.
Radiother Oncol. 2006 Apr;79(1):75-9. doi: 10.1016/j.radonc.2006.03.013.
8
Cancer of the anal canal and local control.肛管癌与局部控制
Rays. 1998 Jul-Sep;23(3):586-94.
9
Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.肛管癌:早期肿瘤≤10毫米(T1或Tis):放疗后的治疗选择及局部失败的原始模式
Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):479-85. doi: 10.1016/j.ijrobp.2004.09.060.
10
[Sphincter-preserving radiotherapy of anal carcinoma].[肛管癌的保留括约肌放疗]
Schweiz Med Wochenschr. 1992 Oct 31;122(44):1689-93.